Haloperidol-induced within-session response decrement patterns and catalepsy in rats: Behavioural dissociation

Behavioural Pharmacology

Volumn 10, Issue 1, 1999, Pages 105-111

  Drinkenburg, W H I M ^a,b   Keith, A B ^a   Sahgal, A ^a   Andrews, J S ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antipsychotic drugs; Catalepsy; Dopamine; Fixed ratio schedule; Haloperidol; Operant behaviour; Rat

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; NONHUMAN; RAT; REINFORCEMENT;

EID: 0032970954     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199902000-00010     Document Type: Article

References (27)

1. Balsara JJ, Jadhav JH, Chandorkar AG (1979). Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology 62:67-69.
2. Braun GA, Poos GI, Soudijn W (1967). Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. Part II. Distribution, excretion and metabolism of haloperidol in Sprague-Dawley rats. Eur J Pharmacol 1:58-62.
3. Das S, Fowler SC (1996). An update of Fowler and Das: anticholinergic reversal of haloperidol induced, within-session decrements in rats lapping behaviour. Pharmacol Biochem Behav 53:853-855.
4. Ellenbroek B, Schwarz M, Sontag K-H, Jaspers R, Cools A (1985). Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats. Brain Res 345:132-140.
5. Ettenberg A (1989). Dopamine, neuroleptics and reinforced behaviour. Neurosci Biobehav Rev 13:105-111.
6. 2. dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 49:538-544.
7. Fowler SC (1990). Neuroleptics produce within-session response decrements: Facts and theories. Drug Dev Res 20:101-116.
8. 2 (raclopride) antagonists. Psychopharmacology 115:24-30.
9. Fowler SC, Senynz I, (1993). Effects of haloperidol on a run-climb-run behavioural task: distance climbed does not alter within-session decrements. Behav Neurosci 107:651-661.
10. Hoffman DC, Donovan H (1995). Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side-effect liability. Psychopharmacology 120:128-133.
11. Horvitz JC, Ettenberg A (1989). Haloperidol blocks the response-reinstating effects of food reward: a methodology for separating neuroleptic effects on reinforcement and motor processes. Pharmacol Biochem Behav 31:861-865.
12. McFarland K, Ettenberg A (1995). Haloperidol differentially affects reinforcement and motivational processes in rats running an alley for intravenous heroin. Psychopharmacology 122:346-350.
13. Meltzer HY (1995). Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci 3:64-75.
14. Niemegeers CJ, Janssen PA (1979). A systematic study of the pharmacological activities of dopamine antagonists. Life Sci 24:2201-2216.
15. Ögren SO (1996). The behavioural pharmacology of typical and atypical antipsychotic drugs. In: Antipsychotics. Czernansky JG (editor). Berlin: Springer. pp. 225-266.
16. 2 dopamine receptors in neuroleptic catalepsy. Eur J Pharmacol 182:327-334.
17. 2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Res 777:51-59.
18. Peacock L, Gerlach J (1996). Antipsychotic-induced side-effects related to receptor affinity. In: Antipsychotics. Czernansky JG (editor). Berlin: Springer. pp. 359-389.
19. Sanger DJ (1986). Response decrement patterns after neuroleptic and non-neuroleptic drugs. Psychopharmacology 89:98-104.
20. Sanger DJ, Perrault G (1995). Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats. J Pharmacol Exp Ther 272:708-713.
21. 3 receptors in the effects of dopamine agonists on operant behaviour in rats. Behav Pharmacol 7:477-482.
22. Soudijn W, Van Wijngaarden I, Allewijn F (1967). Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. Part I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivates in the Wistar rat. Eur J Pharmacol 1:47-57.
23. 1-adrenoceptor antagonism. J Clin Psychopharmacol 15(Suppl 1): 11S-18S.
24. Ushijima I, Kawano M, Kaneyuki H, Suetsugi M, Usami K, Hirano H, Mizuki Y, Yamada M (1997). Dopaminergic and cholinergic interaction in cataleptic responses in mice. Pharmacol Biochem Behav 58:103-108.
25. Willner P, Chawla K, Sampson D, Sophokleous S, Muscat R (1988). Tests of functional equivalence between pimozide pretreatment, extinction and freefeeding. Psychopharmacology 95:423-426.
26. Wilner P, Phillips G, Muscat R, Hood P (1992). Behavioural tests of the dopamine depletion hypothesis of neuroleptic-induced response decrement. Psychopharmacology 106:543-549.
27. Wise RA (1982). Neuroleptics and operant behaviour: The anhedonic hypothesis. Behav Brain Sci 5:39-87.